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Magnetic and noble metal nanocomposites for
separation and optical detection of
biological species
K. Bagga,abcd D. F. Brougham,*ae T. E. Keyesde and D. Brabazon*abcd
Nanoalloys and nanocomposites are widely studied classes of nanomaterials within the context of
biological systems. They are of immense interest because of the possibility of tuning the optical,
magnetic, electronic and chemical properties through particle composition and internal architecture. In
principle these properties can therefore be optimized for application in biological detections such as of
DNA sequences, bacteria, viruses, antibodies, antigens, and cancer cells. This article presents an
overview of methods currently used for nanoalloy and nanocomposite synthesis and characterisation,
focusing on Au–Ag and FexOy@Au structures as primary components in detection platforms for plasmo-
nic and magnetically enabled plasmonic bio-sensing.
1. Introduction
The field of nanocomposite materials is developing rapidly,
with new material structures continuously being fabricated
with the goal of producing synergistic performance improve-
ments over those of the component phases. Structurally
nanocomposite materials can be classified into three key
types1 (a) nanolayered composites composed of alternating
layers of nanoscale dimension; (b) nanofilamentary com-
posites composed of a matrix with embedded (and generally
aligned) nanoscale diameter filaments; and (c) nanoparticulate
composites composed of a matrix with embedded nanoscale
particles.
Eﬀorts have been made to improve the applicability and
stability of composite systems, by combining diﬀerent types of
NPs, e.g., luminescent, or magnetic and so on to introduce new
physical, biological properties and multifunctional behaviour.
Among the various morphologies of hybrid nanocomposite
materials, nanoalloys represent an important class. The term
nanoalloy is used to describe bi- or multi-metallic atom assem-
blies adopting atomic packing schemes with diﬀerent chemical
ordering patterns depending on the phase diagram and for-
mation energies of its constituents. This includes atomically
randomly mixed, multi-domain, core–shell and onion-layered
structures.2–4 The internal structures of nanoalloys are still not
fully understood, despite advances in electron microscopy
including energy-filtering. However, we shall see that, in many
cases, control over optical properties can be obtained using
different architectures, and secondly that there is as yet no clear
consensus on the optimal structures.
Analysis of the literature shows that there has been a
significant increase in the development of nanoalloys and
nanocomposities across the fields of material science, physics,
chemistry and biology. This upsurge in experimental5–7 and
theoretical8,9 work on nanoalloys is due to the unique
enhanced physical optical and chemical binding properties
arising from dimensional control at the nanoscale.10–13 For
the bimetallic nanoalloys examined in this review, their pro-
perties do not depend only on one metal, but also on the
composition and specific chemical ordering of the two metals.
This provides significant additional experimental degrees of
freedom, relative to the bulk alloy, as demonstrated in a large
number of studies14–16 which highlight the role of the particle
size, morphology, and their surface functionalisation in deter-
mining the emergent properties of interest. In this review
we focus on noble-metal-based nanocomposites and hybrid
systems of magnetic nanoparticles (iron oxide NPs) combined
with organic and inorganic constituents (e.g., silica matrices,
semiconductor and metal NPs). Representative examples of
chemical, physical and biosynthetic routes to fabricate these
nanoalloys and nanocomposites (Au–Ag; FexOy@SiO2@Au; and
FexOy@Au) are presented. A selection of papers exemplifying
their development for application in separations and detection
of biological targets are then discussed.
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2. Surface plasmon resonance
The interaction of light with a metal surface results in the
collective oscillation of the surface free electrons. This pheno-
menon is called surface plasmon resonance (SPR).17 The noble
metal components of nanoalloys have been widely used as
eﬃcient probes for localized surface plasmon resonance
(LSPR), due to their strongly enhanced resonance at optical
frequencies, making them excellent scatterers and absorbers in
the visible spectral range. Their surface chemistry provides
possibilities for functionalising with biomolecules, whilst
retaining their bioactivity, which is particularly attractive for
plasmonic sensing. The optical properties arise from diﬀerent
characteristics; higher scattering and extinction cross-sections,
than the alternative semiconductor quantum dots or organic
fluorophores. They have the advantages that they do not photo-
bleach or blink, and that the surface plasmon resonance
wavelength (lspr) is highly sensitive to the local dielectric
environment. The physical requirements for good plasmonic
responses and in particular, narrow resonance bands in bi-
metallic systems include the formation of a monodisperse
collection of particles with a plasmonic layer of even thickness
or the formation of sub-domains of the same size.
2.1 The promise of plasmonic nanocomposites for detection
In the case of nanoalloys, Au–Ag systems for instance, have been
shown to exhibit tuneable LSPR in the visible range (400 to
520 nm) of the spectrum18,19 (see Fig. 124) resulting in plasmonic
nanoparticles (NPs) which do not photobleach or blink and thus
can serve as intense and robust labels for biosensors, immuno-
assays, cellular imaging and surface-enhanced spectroscopies.19
Although, Ag exhibits the sharpest and strongest bands among
all metals, Au is preferred for biological applications due to
its inert nature, biocompatibility,20 and the stable Au–thiol
chemistry which can be exploited for immobilization of
biomolecules. Thus Au–Ag nanoalloys offer a good compromise
between plasmonic efficiency (from Ag) and in vivo biocom-
patibility (from Au) making them important for biological
applications such as biosensors,21 immunoassay22 and as
imaging agents.23
2.2 The promise of magnetic–plasmonic nanocomposites for
detection
Hybrid magnetic–plasmonic nanostructures contain both a
magnetic and plasmonic phase offering a range of possibilities
for detection.25,26 These include optically monitoring the particles
while controlling their motions magnetophoretically, through
application of an external field gradient. To date most investiga-
tions have examined these particles for ex vivo imaging, with the
added possibility of measuring internal forces within cells,27 or
for tracking the transport of active agents within bio-reactors.28
Other investigators have examined simultaneous photoacoustic
(plasmonic) and AC-field (magnetic) irradiation for thermal
ablation of tissue which may prove advantageous for cancer
treatment.26,29 Finally, the possibility of simultaneous mag-
netic resonance imaging in combination with the other func-
tionalities, making use of the magnetic particles effect on the
1H NMR relaxation times, has also been considered.30 Examples
of magnetic nanoparticle cluster enhanced imaging include the
imaging of macrophages and stem cell tracking. The addition of
a plasmonic tag31 may make single magnetic particle tracking in
individual cells tractable, the diffraction limit being overcome in
dark field mode.
The magnetic component of the nanocomposite makes it
possible to control the nanocomposites motion, against back-
ground Brownian motion or other flow dynamics, through the
application of a static field gradient which penetrates tissue
and is non-ionising. The physical requirements for useful
magnetophoretic eﬀects in an applied field gradient have been
described.25 Essentially, the magnetic force is proportional to
the magnetisable volume of the composite particles and to
the diﬀerence in magnetic susceptibility compared to the back-
ground. Larger particles are therefore desirable; however above
the superparamagnetic size limit aggregation is more prevalent,
particularly in the presence of an external field, which drastically
aﬀects the plasmon resonance.
Various types of magnetic nanocomposites can be obtained
by dispersing magnetic particles in a solid matrix,32 in a liquid
matrix,33 or combined with another nanoscale component.34
Amongst those that have been reported are (a) Fe3O4 magnetic
nanoparticle core plasmonic shell nanoparticles Fe3O4@Au;
35–37
(b) Fe3O4/g-Fe2O4 nanoparticles decorated with Au nanoparticles,
including dumbbell arrangements;38,39 (c) Fe3O4@SiO2@Au
nanoparticle cluster core plasmonic shell composites;40 and
(d) plasmonic cores decorated with FeO nanoparticles,41 see
for instance Fig. 2. For the purpose of this article much of the
focus is on type (a); the FeO@Au configuration is the arrange-
ment which is most clearly defined structurally, whose pro-
perties are best understood, and which is most commonly
adopted.
Fig. 1 Experimental spectra for diﬀerent compositions of 60 nm Au/Ag
alloy NPs.24 Reproduced from Ref. 24 with permission from The Royal
Society of Chemistry.
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3. Preparation methods of
nanocomposites
The methods of synthesis of nanocomposites can be broken
into chemical, physical and bio-synthesis methods. These pre-
paration methods are detailed below as applicable to Au–Ag
nanoalloys and FeO@Au nanocomposites.
3.1 Preparation of Au–Ag nanoalloy systems
(a) Chemical synthesis. Methods for chemical synthesis of
Au–Ag nanoalloys and nanocomposites have evolved quickly
over the past few years with a number of strategies developed to
obtain controlled size and shape. Monodisperse Au–Ag colloids
with defined size and shape are required to reproducibly
achieve tuneable and sharp plasmon resonance bands for
diagnostic applications. Reduction of Au and Ag salts mixed
with sodium citrate in refluxing aqueous solution has been
widely reported to yield Au–Ag alloy nanoparticles with tunable
SPR band by varying the molar fractions of gold.42 A seed-
mediated approach43 has also been reported to synthesize Au–Ag
core–shell nanorods from silver ions, using gold nanorods as
seeds. Other methods for the synthesis of Au–Ag nanoalloys
include sputter deposition in ionic liquids,44 photochemical
synthesis,45 and a unique two layer (TL) deposition of Au- and
Ag-incorporated inorganic–organic hybrid silica sols.46
The synthesis of monodisperse Au–Ag nanoalloy particles in
a one-pot approach was reported for the first time by Sun
et al.47 The composition of Au–Ag alloy was controlled through
the ratio of the precursors and growth time during the synthe-
sis. For example, with 2 mmol of AgNO3, 0.2 mmol of HAuCl4,
and a growth time of 1 h (at 120 1C), Au0.60Ag0.40 NPs were
obtained. Oleylamine was used as the surfactant and was
readily removed after synthesis. The Au–Ag nanoalloy showed
compositional dependent plasmonic absorption, indicating
their potential as optical probes for bioimaging.
Zhang et al. reported a multi-step procedure for the synthesis
of highly monodisperse Au–Ag NPs by a galvanic displacement
process, using long chain alkyl amines for tuning the size
distribution of Ag NP seeds.48 In a recent report, synthesis was
carried out by the use of the corresponding Au(I) and Ag(I)
dodecanethiolate complexes, with oleylamine as a solvent and a
reducing agent to obtain Au–Ag nanoparticles sizes ranging from
3 to 6 nm.49 The strongly interacting capping agents (alkylthiolate
ligands) were used to control the growth of the nanoparticles.
Fig. 2 Upper, schematic for formation of (i) Fe3O4 clusters; (ii) Fe3O4@SiO2 nanoparticles; (iii) Au sol decorated Fe3O4@SiO2 NPs; (iv) Fe3O4@SiO2@Au
NPs. Middle TEM images of (ii) and (iv), all scale bars are 50 nm. Lower TEM size distributions of (i) to (iv).40 Reproduced from Ref. 40 with permission from
The Royal Society of Chemistry.
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It should be noted that when oleylamine is used as a solvent,
random Au–Ag compositions are obtained due to differences in
reduction rates of the Au and Ag metal salts. Another commonly
used stabilizing ligand is hexadecylamine (HDA). Monodisperse
Au–Ag alloy nanoparticles of different compositions are prepared
via decomposition of the bimetallic precursor [Au2Ag2(C6F5)4-
(OEt2)2]n in an organic solvent, see Fig. 3.
50 The influence of
reaction parameters (Au : Ag :HDA molar ratio, presence or
absence of reducing agent and reaction temperatures) on the
final size, shape and composition of the Au–Ag NPs were
investigated. It was shown that the different reaction parameters
do not affect the size and the shape of the obtained Au–Ag NPs.
However, these changes can provide variations of the Au content
in the alloy NPs, leading to a tuning of the LSPR band.
(b) Physical synthesis. In recent years, laser ablation has
emerged as a promising method for the synthesis of composi-
tion controlled alloy nanoparticles in liquids. This technique
oﬀers the flexibility to tune the stoichiometry of the alloys,
ablated directly from their corresponding bulk targets (which
could be alloys or single metals). Following the pioneering work
of Lee et al., in the production of Au–Ag alloy nanoparticles,51
this technique was further developed by Shafeev and his
co-workers52 and since then laser induced synthesis of Au–Ag
alloy nanoparticles has been reported widely.53 This method
has proven to be an efficient pathway for the synthesis of pure
ligand-free nanoparticles applicable in toxicity assays.54–57
It is worth noting that compared to chemical synthesis
routes, the laser based synthesis method allows formation of
homogeneous elemental distributions even on a single particle
scale58 in Au–Ag alloy NPs, demonstrated by UV-vis spectro-
scopy as well as TEM-EDX.59 These findings indicate that the
alloying process (elemental segregation) during laser synthesis
is not solely dominated by surface oxidation, but also by the
elemental composition from the ablated target.
Amongotherphysicalnanofabrication techniques, an interesting
example was reported by Bok et al. to prepare Au–Ag alloy nanorods
withmultiple LSPRmodes by electrochemical deposition.60 Varying
the proportional composition of twometals in a plating solution led
to tunability of the resonance wavelength.
(c) Biosynthesis. With the current drive to adopt ‘‘green’’
approaches to design environmentally benign materials and
processes, the biosynthesis approach has proved advantageous
in generating alloy nanoparticles.61,62 Biosynthesis methods,
in contrast to most conventional synthesis methods, can be
carried out at ambient conditions of temperature, pH, and
pressure. The biogenic entities secrete large amount of proteins
leading to metal–ion reduction and morphology control.63
Additionally, the handling of microbial cultures and the down-
stream processing of biomass can be more straightforward to
upscale to industrial levels and can have a lower lifecycle
impact compared to synthetic methods.64 The NPs synthesized
by biological approaches exhibit high bio-catalytic reactivity,
and an enhanced conjugation between the enzyme and the
corresponding metal ion due to the biological carrier matrix.65
It is now very well established that the biological systems such
as microorganisms, plant extracts, and fungi can produce a variety
of nanoparticles through biological pathways.66–68 For example,
production of metal particles of different morphology through
plant and leaf extracts,69 bacteria70 and yeast71 for the reduction of
toxic metals, application of biological templates,72 and use of
different bacterial cells for the noble metals synthesis have been
reported.73,74 Nanoparticle synthesis via the biological route occurs
when themetal target ions from themicroorganism’s environment
are reduced to element metal via the activity of enzymes generated
by the cell or cellular extract. Biosynthesis of nanoparticles can be
either intra or extracellular.75 For the intracellular method the
nanoparticles are fabricated ‘intra’ or ‘in’ the microbial cells by
injecting themetal ions in the presence of enzymes.76 On the other
hand, extracellular synthesis of nanoparticles requires adsorption
of the metal ions on the surface of the cells and thus reduction of
ions in the presence of enzymes.77 The extracellular method is
considered to be more efficient and economical with less compli-
cated processing as compared to intracellular synthesis which
requires additional steps such as ultrasound treatment or reaction
with suitable detergents to release the nanoparticles from cells
during purification.78
Mukherjee et al. demonstrated the use of eukaryotic organ-
isms such as fungi in nanomaterials synthesis; for instance,
Fig. 3 Monodisperse Au–Ag nanoalloys prepared using decomposition of a bimetallic precursor and hexadecylamine (HDA) stabilizing agent.50
Reproduced from Ref. 50 with permission from The Royal Society of Chemistry.
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intracellular fabrication of Au and Ag alloy NPs using Verticillium
sp.79,80 In addition, fungus Fusarium oxysporum was successfully
employed for the extracellular synthesis of Au and Ag nano-
particles.81 Synthesis of bimetallic Au–Ag nanoalloy by fungus
Fusarium oxysporum has been reported by other workers82 and
the role of NADH cofactor has been highlighted in controlling
the composition of the Au–Ag nanoalloys. The synthesis of core–
shell Au–Ag nanoalloys from other fungal strains such as Fusarium
semitectum has also been reported.83 Aqueous solutions of chloro-
aurate ions for Au and Ag ions (1 : 1 ratio) were treated with an
extracellular filtrate of Fusarium semitectum biomass for the
formation Au–Ag nanoalloys. This particular approach is signifi-
cant due to the feasibility of obtaining nanoparticle colloids with
stability over periods of weeks.83
Au–Ag nanoalloy synthesized using yeast cells has also been
demonstrated.84 Chemical analysis of the bioorganic molecules
secreted by the microorganisms indicated that reduction of the
metal ions was performed by enzymatic reactions and that the
metal nanoparticles were stabilized by surface-bound proteins.
Transmission electron microscopic characterization indicated
that the Au–Ag alloy nanoparticles were mainly synthesized via
an extracellular approach and generally existed in the form of
irregular polygonal nanoparticles, see Fig. 4.
3.2 Preparation of FeO core shell plasmonic-oxide
nanocomposites
In this section the development of core shell plasmonic-oxide
nanocomposite materials (containing separate domains) for
biomedical sensing is presented with a focus on magnetic–
plasmonic FexOy@Au (core@shell) and FexOy@SiO2@Au nano-
composites. The challenges in their preparation and their
advantages for optical detection of biomolecules will be
described. Magnetic nanoparticles (MNPs) of iron oxide are
favoured because of their ease of synthesis, chemical stability,
relatively high saturation magnetisation, superparamagnetism
(which contributes to good long term stability) and low toxicity.
In practice it is difficult to distinguish crystallographically
between the magnetic phases usually formed, Fe3O4, and
g-Fe2O3, as they have very similar magnetic properties, hence
in this paper they are referred to as FeO except where the
referenced authors are very clear in their attribution.
A wide range of approaches have been adopted for the
preparation of the FexOy@Au nanocomposites. While it is not
possible to review all of the synthetic methods that have been
used, some key illustrative examples are presented here. The
FexOy core can be prepared by aqueous (usually co-precipitation)
methods, or by thermal decomposition. The gold layer is prepared
by attaching Au NP seeds followed by reduction of HAuCl4, or
sometimes in a single reductive step without using the seed
attachment step. From a synthetic perspective a major challenge
in the formation of the plasmonic shell is preventing autocatalytic
Au reduction/growth, which can result in very thick shells and/or
sub-populations of Au NPs. The situation is exacerbated by the
mismatch in surface energy between Au and FexOy, which reduces
wetting by Au of the FexOy surface. This issue can be partially
addressed kinetically through control of the feed ratio,21 or after
synthesis through extensive centrifugation.21,30 One interesting
approach to control the surface chemistry prior to gold addition is
to passivate the FeO, usually with a silica or alkyl silane layer.
For MNPs prepared by the aqueous route, the FexOy surface
is usually passivated prior to reduction of Au in water. This can
be achieved by surface functionalisation, for instance with
triethoxysilane (TEOS) to produce a thick silica layer.31,85 In
both the examples, Au seeds were used in a two step plasmonic
layer preparation. In the latter case85 the FexOy component was
c. 10 nm and the Au layer was thin, o10 nm. ICP analysis
demonstrated a composition of 44% Fe3O4, 8% Si and 48% Au,
which is consistent with the proposed structure. The advantages
of outer Au layers over solid nanoparticles for tuning the optical
response and for photothermal ablation were identified. However
the silica content was rather high and as the authors note each
particle probably contains multiple cores, demonstrating some
uncertainty about the structure/structure distribution formed.
In the former example,36 the silica layer was again thick
(85 nm), with a 30 nm Au shell, the FexOy NPCs comprising c.
2% by wt of the total the nanocomposites were c. 170 nm in
size. It is apparent that, despite the findings in the latter work,
in several other cases there are significant fractions of
magnetic-only and plasmonic only particles present. In TEM
micrographs the z-contrast diﬀerence between Au and Fe
should be suﬃcient for unambiguous confirmation of nano-
scale mixing, so a proper attribution should usually be possible.
FeO passivation has also been reported for 40 nm. FexOy NP
clusters achieved using bi-functional ligands such as MPEG-
SH21 to produce a thin Au shell (with Au : Fe of 0.15 : 1). By
controlling the kinetics of Au layer growth (no Au seeds) while
maintaining very low Au content, secondary nucleation could
be avoided and the morphology of the layer could be altered
from being ‘partial’ to ‘knobbly’ to ‘smooth’.
In many cases MNPs produced by the thermal route are
surface passivated and phase transferred into water for the gold
Fig. 4 TEM images of Au–Ag nanoparticles formed by reaction of a
mixture of 1 mM HAuCl4 and 1 mM AgNO3 with 60 g Fusarium oxysporum
wet biomass for 96 h.82 Reproduced from Ref. 82 with permission from
John Wiley & Sons, Inc.
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coating. Bi-functional silanes such as aminopropyltriethoxy-
silane (APTES), which form a monolayer (or at least a thin
layer) with an outer amino group ensuring water dispersibility
are typically used. In one notable case86 the exchange of the
surface layer of oleic acid/octylyamine present after the thermal
reaction was reported. The Au layer was again grown in two
steps, with initial attachment of 2 nm Au NPs. This approach
could be used to take advantage of the improved crystallinity,
size control and monodispersity of the FexOy NPs from the
thermal route. Aside from the advantage of size control this
is the more likely route to colloidal stability in aqueous or
biological environments, which ultimately requires steric as
opposed to electrostatic stabilisation of the nanocomposite.
Other bi-functional ligands can also be used. In an interesting
report,31 highly uniform 18 nm MNPs, prepared by the Colvin
method87 to ensure uniformity followed by a variation on the
thermal decomposition method to ensure crystallinity,38 were
ligand exchanged with TMAOH for phase transfer into water.
Passivation with mercapto-undecanoic acid (MUA) was then
applied to prevent localised nucleation (and hence formation
of a dumbbell structure) before initial attachment of 1.5 nm Au
seeds and subsequent reduction of HAuCl4. The authors noted
improved colloidal stability as compared to the use of silanes.
One could speculate, on the basis of the report noted above,21
that a single step reduction of HAuCl4 might suﬃce, given the
pendant thiol present in both cases. However, identifying the
exact conditions to control the layer thickness and shape would
be challenging.
Thermal decomposition methods have also been used for
preparing both the FexOy core and the Au shell by sequential
decomposition of iron and then gold precursors in situ in non-
aqueous media.35 In this case the nanocomposites were pro-
cessed by centrifugation and subsequently deposited as thin
films by molecularly mediated assembly for detection applica-
tions. In a very well-known example from the Sun group37
multiple plasmonic layers were deposited and the non-aqueous
suspensions were dried and resuspended with citrate and CTAB
to form a stable aqueous suspension, presumably with a stabi-
lising CTAB bilayer. In both these cases the FexOy surface was
not passivated before reduction of HAuCl4 in organic media (no
Au seeds), using oleylamine as the ‘gentle’ reducing agent in the
latter case. This study37 is a particularly elegant demonstration
of the tuning of the plasmonic response by stepwise addition
of increasingly thick layers Au or Ag to FexOy@Au NPs. A pro-
gressive red or blue shift of the lspr value was observed of up to
27 nm (red) on increasing the Au shell thickness by 2.5 to 3 nm,
and of up to 33 nm (blue) with a similar increase in the Ag shell
thickness, on the gold coated cores. The influence of core
permittivity and size on the plasmonic tunability has been
analysed.86 A comprehensive theoretical treatment demon-
strated the feasibility of geometric plasmon tunability over a
range of core permittivity’s and shell thicknesses. The method
also enables extraction of the dielectric properties of the core
from the plasmonic response, under ideal conditions.
As an interesting alternative, the Sun group have prepared
dumbbell shaped Au–Fe3O4 NPs by epitaxial growth of iron
oxide on Au NPs, by decomposition of Fe(CO)5.
88 In another
prominent article the layered approach was taken a step
further89 to produce a silane@FeO@Au nanocomposite, with
a quasi-spherical silane core surface decorated with silica
stabilised FeO NPs surrounded by a thin Au shell (1–3 nm Au
NPs were bound initially). While interesting chemically, and
promising from the perspective of high selective DNA detection
(DNA melting curves were show), it is unlikely that the mag-
netic content is sufficiently high for magnetophoretic control.
4. Bio-sensing applications with
Au–Ag and FexOy@Au nanoalloys
(a) Nanoalloys in SERS biosensing applications
Raman based diagnostics of tissue and cell (prokaryotic and
eukaryotic) samples is reaching maturity for a broad range of
pathogenic and non-pathogenic disease states.90–92 Indeed,
there are now numerous commercial companies offering clinical
diagnostics based on Raman spectroscopy. Applications of SERS
as a diagnostic tool are however still evolving. Biomarker detec-
tion is probably one of the most active areas of SERS bioanaly-
tical research. One of the most widely implemented approaches
is incorporation of SERS into sandwich-style bioassays, where a
biomolecular recognition moiety e.g. oligonucleotide, aptamer,
peptide or antibody is assembled on the SERS substrate to target
the analyte.93 Frequently the SERS substrate is a nanoparticle or
in some instances a macroscopic SERS interface, e.g. roughened
gold or nanofabricated array on which the capture agent is
assembled. There are two relatively common formats; in the
first the target is captured between a capture and reporter strand
motif, both bound to SERS substrates, e.g. capture and probe
DNA, and detection occurs due to the enhanced signal at the
target as it is sandwiched between two plasmonic nanoparticles
or a particle and SERS active substrate on which the capture
strand is immobilised. The Raman signature of the target is the
analytical signature of interest, and discrimination is made on
the basis of the Raman fingerprint of the target.94 In an alter-
native and much more common approach, the signature that is
recorded is that of a SERS or SERRS (surface enhanced reso-
nance Raman) active dye which is bound directly to the probe
motif or to a nanoparticle (e.g. core shell structure) on the probe
motif. Examples of this approach have been used with anti-
bodies and particularly widely with oligonucleotides across a
broad range of disease states, and this format can be either
solution based or interfacial where one of the SERS substrates is
a macroscopic surface. Very low limits of detection for target
analytes have been reported using this approach.95
Conventional Raman spectroscopy, is often implemented
via microscopy or for in vivo diagnostics with fibre optic
modality which is often non- or minimally invasive. Although
Raman spectra of composite biological matrices can be challen-
ging, robust chemometric analysis of the complicated but
characteristic spectra have really advanced this field toward
clinical and point of care applications. Research activity in the
field of SERS applied to diagnostics is extensive and a detailed
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review and historical perspective of this is beyond the scope of
the present article.96 Instead the reader is directed to a number
of insightful reviews which have been published recently.97–99
Whereas, the vast majority of diagnostic SERS applications
have focussed on single metal species, metal composites and
nanoalloys are being increasingly applied in SERS.100–102 The
advantages of using nanoalloys in this context are the possibility
of generating higher signal enhancement and improving biocom-
patibility.103–107 This is particularly the case in applying silver to
bio diagnostics. Silver can yield very high Raman enhancements
and toxicity induced by silver can be mitigated by coating silver in
gold. Moreover, unlike pure Ag or Au NPs, Au–Ag alloy NPs exhibit
higher stability and surface enhancement108 which can potentially
be applied to living cell imaging.109 In the case of the magnetic–
plasmonic materials the presence of the magnetic component
provides possibilities for concentrating the particles to obtain the
most intense Raman response from the probes. In a clinical
setting such magnetic ‘pre-concentration’ could also be used to
isolate the modified particles from background medium.110
Herein, an overview is presented of the application of nano-
alloys (Au–Ag and magnetic plasmonic) in SERS for bio-
diagnostics and sensing with selected approaches from recent
literature.
(b) Plasmonic Au–Ag nanoparticle systems
As discussed above, optical responses for Au–Ag NPs depend
predominantly on their composition and configuration (alloy
and core–shell). The plasmon absorption band of Au–Ag NPs
lies at an intermediate position between pure Au and Ag NPs
and can similarly lead to amplification of SERS signal from
surface localized molecules.111 Indeed superior SERS perfor-
mances of Au–Ag alloy nanoparticles have been reported.
In view of this, SERS application of different configuration
of Au–Ag NPs is presented together with an insight on their
performance.
Core@shell structures. In an early example of a nanoalloy
applied in a SERS sandwich assay, Tian and co-workers101
described fabrication of Ag@Au (core@shell) NPs labelled with
monoclonal goat anti mouse antibodies for IgG for immuno-
recognition and with thiophenol as the Raman reporter. Synthesis
of Ag@Au NPs was carried out by the seed-growth method. The
captured antibody was assembled onto a planar silver coated glass
surface. It was found that the SERS activity of aggregated colloids
depends significantly on the molar ratio of Ag to Au. About
10 times more intense SERS activity was recorded with the
increase of the Au molar fraction in AgcoreAushell compared to
Ag colloids.
Recently, application of Au@Ag core–shell NPs as a hydrogen
peroxide (H2O2) biosensor was reported with hemoglobin-
chitosan-1-butyl-3-methyl-imidazolium tetrafluoroborate (Hb-
CHIT-BMIM  BF4) composite film.21 The fabricated biosensor
displayed a detection limit of 4  107 M (S/N = 3) and good
electrocatalytic activity was found for reduction of H2O2 in the
range from 1.0  106 to 1.0  103 M. The excellent detection
limit was attributed to the synergistic effect of the Au@Ag core–
shell NPs and Hb-CHIT-BMIM  BF4 (with a Michaelis–Menten
constant of (KM) 4.4  104 M, confirming high affinity). This
study opens up new opportunities for the design of enzymatic
biosensors.
Bimetallic surfaces. It has been shown that the biosensing
sensitivity of mono-metallic surface plasmon resonance is signifi-
cantly improved by using bi-metallic nanoparticles (Au/Ag NPs)
coated on solid functionalized supports (for instance, glass
substrates) before specific immobilization of biomolecules.
Vo-Dinh’s group reported improved SERS enhancement com-
pared to a single gold film while maintaining signal stability.112
This group further advanced the approach of ‘metal film over
nanospheres’ (MFON) by applying Ag–Au alloy films over poly-
styrene spheres (430 nm diameter) for their SERS substrate
onto which DNA sequence for dengue virus was analysed.113
The substrates were prepared by using 5 nm Ti over the PS
array, presumably to adhere the metal to the spheres, over
which 100 nm of Ag and of Au were deposited (see Fig. 5).
Again, the signal was transduced through changes to SERS
intensity instigated by altering distance between the SERS
reporter and the substrate. In this case the distances were
shortened and SERS switched on hybridization of the target
which caused the immobilised DNA to form hairpin structures.
Taking into account the number of molecules under the exciting
laser irradiation area, the authors estimated they were able to
detect attomole quantities of the single stranded target DNA.
A similar approach has been applied to SERS detection of
whole pathogens using nanoalloys. For example Waluk and his
group114 reported that an Au–Ag bimetallic SERS surface can
provide strong Raman enhancement, with high reproducibility,
for identifying the pathogenic bacteria, E. coli, S. enterica and
S. epidermidis from blood samples. The SERS spectra of these
four bacterial species were obtained on a vancomycin-coated
hybrid surface, see Fig. 6. Vancomycin is an antibiotic useful for
the treatment of a number of bacterial infections. Thus, vanco-
mycin coated SERS substrate was utilized to selectively captured
bacteria from blood samples and also increased the Raman
signal in contrast to the bare surface. The results show that
the intensity of SERS signals from the vancomycin-coated sub-
strate in comparison with the bare substrate isB8 times higher
for S. epidermidis (Fig. 6) and B. megaterium,B4 times higher for
S. enterica, and B5 times for E. coli. Higher signal intensity for
S. epidermidis and B. megaterium than for E. coli and S. enterica
was attributed to the fact that vancomycin is more effective
against Gram positive than Gram-negative bacteria.
Alloy nanoparticles. A study by Intartaglia et al.115 reported
SERS investigations on crystal violet (CV) chemisorbed on the
laser generated ligand-free Au–Ag NPs at different laser wave-
lengths. CV is an effective stain used for highlighting acidic
components of tissues especially for nerve tissue types. A SERS
enhancement factor in this case of about 5.7 105 was reported
compared with the flat Au–Ag surface.
Moreover, the use of diﬀerent Au–Ag alloy nanoprobes
in combination with the pure gold nanoprobes has allowed
creation of a multiplex DNA biosensor.116 Nanoparticles with
different noble metal compositions (Au–Ag) were prepared in an
alloy configuration and were functionalized with thiol-modified
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ssDNA (nanoprobes). These nanoprobes were then used for the
simultaneous specific identification of several mRNA targets
involved in cancer development, thus enabling one pot multi-
colour detection of cancer expression. The different metal com-
position in the alloy yield different ‘‘colors’’ that can be used
as tags for identification of a given target. Subsequently the
multicolour nanoprobes were used for molecular recognition of
a number of differently spliced variants of relevant genes
(including some involved in chronic myeloid leukemia; BCR,
ABL, BCR–ABL fusion product).
Cai et al.,117 in a similar approach reported on the use of
aptamer modified Au–Ag nanostructures for detection of
human breast cancer MCF-7 cells using SERS. The nano-
particles were modified with both aptamer and Rhodamine
6G which was used as a Raman marker, and the authors found
that their probes discrimination of MCF-7 cells from normal
breast cells in vitro. Furthermore, because of their high NIR
cross section, the particles could be for selective photothermal
destruction of the cancerous cell line.
Cao et al.118 described the application of bimetallic NPs to
develop a specific colorimetric DNA biosensor based on oligo-
nucleotide functionalized AuAg-nanoprobes for the specific
detection of a DNA sequence from TP53-a gene involved in
cancer development. This study provided a successful alterna-
tive detection method (colorimetric change) diﬀerent from
the conventional Au system. This could be advantageous for
monitoring of multiple oligonucleotide targets in one sample,
an essential requirement for clinical analysis in multicolour
immunoassays.
Zheng et al. reported Au–Ag alloy nanoparticles biosynthe-
sized by yeast cells applied to fabrication of a sensitive electro-
chemical vanillin sensor.84 Under optimal working conditions,
the oxidation peak current of vanillin at the sensor linearly
increased with its concentration in the range of 0.2–50 mM with
a detection limit of 40 nM. This vanillin sensor was successfully
applied to the determination of vanillin from vanilla bean and
vanilla tea samples, suggesting that it may have practical
applications in natural product monitoring. These electro-
chemical investigations revealed that the vanillin sensor based
on Au–Ag alloy nanoparticles, coupled with a modified glassy
carbon electrode (GCE), provided a five-fold enhancement in
electrochemical response compared to bare GCE.
(c) Magnetic–plasmonic@Au nanoalloys
In the last few years the literature on magnetic/plasmonic
materials for sensing or detection has expanded rapidly. It is
Fig. 6 (a) SERS spectra of healthy human blood (red) and S. epidermidis spiked human blood (black) on the vancomycin-coated Ag–Au hybrid surface.
(b) SEM image of S. epidermidis selectively captured from blood components on the hybrid substrate. The inset shows a magnified view of
S. epidermidis.114 Reproduced from Ref. 114 with permission from The Royal Society of Chemistry.
Fig. 5 Illustration of the label-free complementary target DNA detection scheme, Vo-Dinh et al.113 Reproduced from Ref. 113 with permission from The
Royal Society of Chemistry.
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not possible to present an exhaustive review within this article,
so a few noteworthy recent examples are presented to provide
an indication of the current state-of-the-art and the potential of
these materials. In a recent report,40 a Fe3O4@SiO2@Au nano-
composite suspension for combined magnetic responsiveness,
biosensing and bioimaging was produced. Thermal FeO synthe-
sis was applied, with the Stober method used to add TEOS, and
subsequently APTES, the Au coating was added in a single step to
prepare NPs comprising a 74 nm FeO cluster core, 20 nm thick
SiO2 layer and 30 nm Au shell. Two-photon luminescence (TPL)
3D-imaging of single cells, NIR SERS and cell collection by
magnetic separation were demonstrated. Magnetically directed
assembly of particle chains was also shown in suspension which
further increased the TPL intensity by an order of magnitude,
apparently due to plasmon coupling.
The Ray group recently reported26 an aptamer-conjugated
Fe3O4@Au nanocomposite (50 nm hydrodynamic size) suspen-
sion for targeted imaging/magnetic separation of selected cells
from a mixture of diﬀerent cancer cells, see Fig. 7. The materials
were prepared by the Massart (co-precipitation) route, with
TMAOH coating and multiple Au reductions to produce a thick
shell for binding thiol-modified Cy3-bound S6 aptamers specific
to (HER2+) SKNBR-3 cells. With a binding density of 4100
aptamers/NP and specific uptake it was reported that irradiation
for 10 minutes (670 nm, 2.5 W cm2) resulted in selective
irreparable cellular damage to most (apparently 499%) of the
targetted cells with 493% viability of the remaining HER2-cell
types. It was anticipated that the specificity would increase in
clinical settings due to better heat dissipation.
More recently the Ray group reported29 multifunctional
popcorn-shaped Fe@Au nanocomposite (20 nm Fe metal core
size) cystamine-linked with M3038 antibodies (4100 AB/NP).
The high curvature Au tips provided a large SERS enhancement,
producing sensitivity as low as 100 colony forming units per mL
of MDR bacteria, which could enable label-free SERS imaging.
Targeted separation and selective and irreparable photothermal
(670 nm 1.5 W cm2, 10 min) cellular damage to M308+ multi-
drug resistant Salmonella DT104 was demonstrated.
Cancer cell separation enabled by antibody targeted SERS and
fluorescence dual-encoded magnetic nanoprobes has recently
been reported using an interesting NP assembly strategy.119 In
this case, plasmonic nanorods (Au@Ag NRs) were attached to a
magnetic FeO (250 nm) core to enable a strong magnetophoretic
eﬀect. This in turn was silica coated (78 nm shell), with fluores-
cent quantum dots embedded in that component. The materials
enabled rapid, specific cancer cell separation and may have
potential for high-throughput analysis.
5. Concluding remarks
This review presents an overview of the various chemical,
physical and biosynthesis methods for synthesis of Au–Ag
nanoalloys and FeO@Au nanocomposites and their application
in bio-sensing. In the case of Ag–Au nanoalloys, the use of core–
shell structures allows use of the well-established Au–thiol
chemistry for binding biospecies.118 However, this arrangement
requires cumbersome synthesis, in part because the controlled
Fig. 7 Upper bright field inverted microscopy of (left) aptamer-conjugated Fe3O4@Au NPs, attached to SK-BR-3 breast cancer cells after irradiation,
(right) bright-field inverted images of SK-BR-3 cells alone after irradiation followed by staining with trypan blue. Lower; cell viability when S-6 aptamer-
conjugated Fe3O4@Au NPs were attached and irradiated (left) SK-BR-3, MDA-MB, and HaCaT cells, (right) SK-BR-3 and HaCaT cell mixtures (1 : 0.01).
Reprinted with permission from ref 26 (Z. Fan, M. Shelton, A. K. Singh, D. Senapati, S. A. Khan and P. C. Ray, ACS Nano, 2012, 6(2), 1065–1073) Copyright
(2012) American Chemical Society.
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deposition of Au over Ag is difficult to achieve due to galvanic
displacement.126 Additionally, due to inter-layer metal diffusion at
high temperatures, the optical properties of the core–shell nano-
particles can be compromised during synthesis.126 Nanoparticles
with uniform or non-uniform atomic distribution can be more
easily synthesized and can still exhibit remarkable and tunable
optical properties, furthermore these NPs display a single plasmon
absorption band in the visible spectrum, while core–shell NPs
generally present a double plasmon band.127 However, the presence
of surface Ag atoms can increase toxicity and reduce chemical
stability. In the coming years the functionality of the different
bimetallic nanoparticles arrangements will lead to informed
decisions as to which different nanoalloy structures are the best
for their associated analytical applications.
A wide range of viable synthetic approaches for the produc-
tion of FexOy@Au NPs are noted in this review. In the last
few years the literature on magnetic/plasmonic materials for
sensing or detection has also expanded rapidly. Some note-
worthy recent examples presented above provide an indication
of the current state-of-the-art. It is apparent that multifunc-
tional magneto-plasmonic nanocomposites can be produced
and their advantages can be realised in a laboratory setting.
The most recent literature suggests that colloidal stability in
biological fluids and non-toxicity, which are critical for any
eventual application in vivo, are increasingly being addressed.
However, this technology is not yet suﬃciently mature to be
found in commercial applications for separation, detection or
regeneration.
Interestingly, for both Au–Ag and FexOy@Au nanoalloy/
nanocomposites presented in this review, a diverse range of
synthesis methods continues to be applied, suggesting the
absence of consensus on which approach is best. In the bio-
synthesis and physical synthesis routes, no additional reducing
agents, such as hydrazine hydrate and trimethylamine borane
(TMAB), or potentially toxic solvents, such as toluene, are
required; providing a greener production process. A relatively
small number of papers have been published on the biosynthesis
of core@shell NP structures128 which may be due to the difficulty
in achieving consistent control over nanoparticle size and shape
via this route. This appears to be particularly relevant for intra-
cellular synthesis, however, there may be possibilities for using
sequential extracellular synthesis to fabricate core@shell struc-
tures. Today, chemical synthesis provides for more reproducible,
uniform and controlled quantity of nanoalloy/nanocomposite
production at scale than the alternatives. Hence from a quality
control and performance evaluation viewpoint, the chemical
route retains significant advantages.
Important challenges for production of nanoalloys include
the control of the NP size and composition, as well as the
prevention of NP aggregation. Stabilizing the surface by capping
it with a shell of organic molecules can lead to controllable
size, shape and surface properties. The majority of papers,
including those discussed in this review, present the synthesis
of isotropic spherical structures for nanoalloys. Very few
methods have been reported for fabricating nanoalloys with a
non-spherical shape.122 Given the unique physical and chemical
properties that can be achieved from defined geometry of nano-
alloys,123,124 it is likely that this possibility will be exploited in the
near future. Density function theory (DFT) modelling could also
be used to identify target structures for synthesis, with expected
enhanced functionalities.125
An application of increasing importance for plasmonic
nanoalloy substrates is in surface enhanced Raman spectro-
scopy as, due to its interfacial nature, SERS is inherently suited
to chip based diagnostics. By combining SERS arrays for detec-
tion with microfluidic strategies for sample manipulation it is
anticipated that in a short time advanced SERS detection of
biomarkers in complex samples (including cells or even tissue)
may be possible at low volume and with minimal oﬀ-chip pre-
processing. In particular nanoalloys are likely to find growing
applications as probes for plasmonically enhanced detection,
a key component in innovative diagnostics, and even as agents
in therapies.120,121 The most recent literature suggests that
development of nanoalloy substrates in SERS diagnostics will
be driven by research into targeting, control of toxicity, and,
once again, by the optimal nanocomposite composition and
architecture for the actual applications.
In conclusion, the development of plasmonic nanoalloys
and nanocomposites is gradually moving from fundamentals
and proof of concept studies, which have shown exciting
potential, towards implementation. We suggest that success
in that activity will require more detailed performance com-
parisons to be made between alternative nano-architectures
and, in time, between alternative devices. This will first
require the establishment of standards, or at least of agreed
norms, for evaluating these novel materials for the identified
fields of use.
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